Venkatesh Krishnan

7.3k total citations · 1 hit paper
84 papers, 5.3k citations indexed

About

Venkatesh Krishnan is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Venkatesh Krishnan has authored 84 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 29 papers in Molecular Biology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Venkatesh Krishnan's work include Estrogen and related hormone effects (24 papers), Effects and risks of endocrine disrupting chemicals (10 papers) and Toxic Organic Pollutants Impact (9 papers). Venkatesh Krishnan is often cited by papers focused on Estrogen and related hormone effects (24 papers), Effects and risks of endocrine disrupting chemicals (10 papers) and Toxic Organic Pollutants Impact (9 papers). Venkatesh Krishnan collaborates with scholars based in United States, United Kingdom and Italy. Venkatesh Krishnan's co-authors include Stephen Safe, Ormond A. MacDougald, Xiaofang Wang, Isabelle Gerin, Kyle M. Sousa, Ming‐Jer Tsai, Michael J. Santostefano, Weston W. Porter, Sophia Y. Tsai and Yanfei Li and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Venkatesh Krishnan

79 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of bone mass by Wnt signaling

2006 1.1k citations Venkatesh Krishnan Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Venkatesh Krishnan

Since Specialization

Citations

This map shows the geographic impact of Venkatesh Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Venkatesh Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Venkatesh Krishnan more than expected).

Fields of papers citing papers by Venkatesh Krishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Venkatesh Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Venkatesh Krishnan. The network helps show where Venkatesh Krishnan may publish in the future.

Co-authorship network of co-authors of Venkatesh Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Venkatesh Krishnan. A scholar is included among the top collaborators of Venkatesh Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Venkatesh Krishnan. Venkatesh Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	69O Novel regimens for persistent/recurrent rare epithelial ovarian carcinomas (EOCs) selected according to biomarker status: ENGOT-GYN2/GOG-3051/BOUQUET phase II study results 2025 ·ESMO Open ·(unknown), Robert F. Miller, Jubilee Brown, JW Kim, (unknown), Andrés Redondo, Lauren E. Yauch, Max Dieterich, (unknown), Venkatesh Krishnan, Sana Intidhar Labidi‐Galy, Fatih Köse, Sandro Pignata, Lucy Gilbert, (unknown), Charlie Gourley, David M. O’Malley, June‐Yong Lee, Dominique Berton-Rigaud, David M. Gershenson	0
2	A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04) 2024 ·International Journal of Gynecological Cancer ·(unknown), Mary McCormack, Yong‐Man Kim, Sharad Ghamande, (unknown), Domenica Lorusso, Lisa Barraclough, Lucy Gilbert, (unknown), Chien‐Hsing Lu, Renaud Sabatier, Nicoletta Colombo, Youyou Hu, Venkatesh Krishnan, Luciana Molinero, Yuning Feng, Nicole J. Kim, Marcela Castro, Yvonne G. Lin, Bradley J. Monk	16
3	Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease 2023 ·The Journals of Gerontology Series A ·Shalender Bhasin, Venkatesh Krishnan, Thomas W. Storer, Mitchell S. Steiner, Adrian S. Dobs	19
4	Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp Speed and Oncology Drug Development 2023 ·The Journals of Gerontology Series A ·(unknown), William J. Evans, Roger A. Fielding, Venkatesh Krishnan, Robert H. Carter, (unknown), Jack M. Guralnik, Lloyd B. Klickstein, Peter Marks, Alison Moore, (unknown), Shalender Bhasin	0
5	Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States 2022 ·Advances in Therapy ·Casey Choong, Mark Belger, Alisa E. Koch, Kristin J. Meyers, Vincent C. Marconi, Hamed Abedtash, Douglas E. Faries, Venkatesh Krishnan	0
6	DOP65 Mirikizumab regulates genes involved in anti-TNF resistance and ulcerative colitis disease activity 2020 ·Journal of Crohn s and Colitis ·(unknown), Jochen Schmitz, Nick Powell, (unknown), Klaus Gottlieb, (unknown), Bochao Jia, Jay Tuttle, William J. Sandborn, B E Sands, Venkatesh Krishnan	3
7	Novel Therapeutic Approach for Neurogenic Erectile Dysfunction: Effect of Neurotrophic Tyrosine Kinase Receptor Type 1 Monoclonal Antibody 2014 ·European Urology ·Guiting Lin, Huixi Li, Xiaoyu Zhang, Jianwen Wang, Uwais B. Zaid, Melissa T. Sanford, (unknown), Alex K. Wu, Lin Wang, (unknown), Helen Kotanides, Venkatesh Krishnan, Guifang Wang, Hongxiu Ning, Lia Banie, Ching‐Shwun Lin, Gary G. Deng, Tom F. Lue	36
8	Inhibition of Activin A Ameliorates Skeletal Muscle Injury and Rescues Contractile Properties by Inducing Efficient Remodeling in Female Mice 2014 ·American Journal Of Pathology ·Benjamin C. Yaden, (unknown), Jonathan M. Wilson, (unknown), (unknown), Amita Datta‐Mannan, Pamela K. Shetler, Johnny E. Croy, Guoli Dai, Venkatesh Krishnan	26
9	Sweet Taste Receptor Deficient Mice Have Decreased Adiposity and Increased Bone Mass 2014 ·PLoS ONE ·B Simon, Brian S. Learman, Sebastian D. Parlee, Erica L. Scheller, Hiroyuki Mori, William P. Cawthorn, Xiaomin Ning, Venkatesh Krishnan, Yanfei Li, Björn Tyrberg, Ormond A. MacDougald	58
10	Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition 2012 ·Journal of Clinical Investigation ·Hiroyuki Mori, (unknown), Michael A. Reid, Kenneth Longo, Isabelle Gerin, William P. Cawthorn, Vedrana S. Susulic, Venkatesh Krishnan, Andy Greenfield, Ormond A. MacDougald	142
11	Involvement of estrogen receptor β in maintenance of serotonergic neurons of the dorsal raphe 2012 ·Molecular Psychiatry ·Hitoshi Suzuki, Rodrigo P. A. Barros, Nobuhiro Sugiyama, Venkatesh Krishnan, Benjamin C. Yaden, (unknown), Margaret Warner, Jan-Åke Gustafsson	65
12	Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 5: Combined A- and C-ring structure–activity relationship studies 2007 ·Bioorganic & Medicinal Chemistry Letters ·Timothy I. Richardson, Jeffrey A. Dodge, Yong Wang, Jim D. Durbin, Venkatesh Krishnan, Bryan H. Norman	31
13	Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 3: Synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification 2007 ·Bioorganic & Medicinal Chemistry Letters ·Timothy I. Richardson, Jeffrey A. Dodge, Gregory L. Durst, Lance A. Pfeifer, (unknown), Yong Wang, Jim D. Durbin, Venkatesh Krishnan, Bryan H. Norman	42
14	Effects of Estradiol and Progesterone on Vertebral Collagen, Glycosaminoglycans and Phosphatases in Ovariectomized Adult Rats 2003 ·Hormone and Metabolic Research ·Venkatesh Krishnan, J. Arunakaran, P. Govindarajulu, N. Srinivasan	9
15	Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling 2003 ·Molecular Endocrinology ·Venkatesh Krishnan, Terry L. Moore, Yanfei Li, Leah M. Helvering, Charles A. Frolik, (unknown), Patricia Ducy, Andrew G. Geiser	114
16	Molecular Mechanism of Inhibition of Estrogen-Induced Cathepsin D Gene Expression by 2,3,7,8-Tetrachlorodibenzo- p -Dioxin (TCDD) in MCF-7 Cells 1995 ·Molecular and Cellular Biology ·Venkatesh Krishnan, Weston W. Porter, Michael J. Santostefano, Xiahong Wang, Stephen Safe	172
17	Chlorinated hydrocarbons: estrogens and antiestrogens 1995 ·Toxicology Letters ·Stephen Safe, Venkatesh Krishnan	47
18	Aryl hydrocarbon (Ah) receptor-independent induction of Cypla2 gene expression by acenaphthylene and related compounds in B6C3F1 mice 1994 ·Carcinogenesis ·(unknown), Michael J. Santostefano, Inna Goldfarb, (unknown), Michael J. Myers, (unknown), Harry V. Gelboin, Venkatesh Krishnan, Stephen Safe	45
19	Synergistic activity of polynuclear aromatic hydrocarbon mixtures as aryl hydrocarbon (Ah) receptor agonists 1993 ·Chemico-Biological Interactions ·(unknown), (unknown), Venkatesh Krishnan, Michael J. Santostefano, (unknown), Stephen Safe	61
20	Mechanism of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells 1993 ·Molecular and Cellular Endocrinology ·Xiaofang Wang, Weston W. Porter, Venkatesh Krishnan, T.R. Narasimhan, Stephen Safe	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact